AKORN INC (AKRX)
 
Quote Price $12.04
Price change for today in $ 0.03
Price change for today in % 0.25
Open Price $11.99
Previous Close $12.01
Daily Range $11.79 - $12.12
52-Week Range $4.97 - $12.25
Volume 566,485
 
 
Brokerage Analyst Recommendations 
4 Brokerage Firms Covering AKRX
 
  
Strong Buy
3 		Buy
1 		Hold
0		 Sell
0		 Strong Sell
0
Average Broker Recommendation (ABR):1.25 
 
Description
Akorn, Inc. manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others. They also market ophthalmic surgical instruments and related products. Customers include physicians, optometrists, wholesalers, group purchasing organizations and otherpharmaceutical companies. They also provide contract manufacturingservices.
 
1925 W. FIELD COURT SUITE 300
LAKE FOREST, IL
60045, USA
Phone: 8472796100
Fax: 800-943-3694
Web: http://www.akorn.com
Email: investor.relations@akorn.com		 Industry:MED-GENERIC DRG
Sector: Medical
Fiscal Year End:December
Last Reported Quarter:12/31/11
Next EPS Date:03/06/12
 
Capital Structure Solvency and Cash Flow
No comments yet. Be the first


 
6make a comment about Capital Structure Solvency and Cash Flow
 
Governance Social Responsibility and Employee Relations
No comments yet. Be the first
make a comment about Governance Social Responsibility and Employee Relations
 
Acquisitions Divestitures and Joint Ventures
No comments yet. Be the first
make a comment about Acquisitions Divestitures and Joint Ventures
 
Recent and Upcoming Events
Feb 09, 2012 07:59 Akorn has the Best Relative Performance in the Pharmaceuticals Industry (AKRX, SLXP, AGN, MYL, ENDP)
Feb 08, 2012 20:41 Akorn Inc. (AKRX) Corporate Event Announcement Notice
Feb 08, 2012 07:11 Akorn, Inc.
Feb 07, 2012 20:40 Akorn Inc. (AKRX) Corporate Event Announcement Notice
Feb 07, 2012 08:14 Short-term Underperformance Detected in Shares of Salix Pharmaceuticals in the Pharmaceuticals Industry (SLXP, MRX, AKRX, ELN, TEVA)
Feb 07, 2012 08:00 Akorn, Inc. Announces Fourth Quarter 2011 Earnings Release and Conference Call Information
Feb 06, 2012 10:35 40.8% Return Seen to Date on SmarTrend Akorn Call (AKRX)
Feb 03, 2012 14:59 Shares of Akorn Rise Above Previous 52-Week High
Feb 01, 2012 14:57 Akorn: 52-Week High Recently Eclipsed (AKRX)
Feb 01, 2012 07:58 Akorn has the Best Relative Performance in the Pharmaceuticals Industry (AKRX, SLXP, NVO, QCOR, OPTR)
Jan 30, 2012 10:08 Uptrend Call Working As Akorn Stock Rises 29.1% (AKRX)
Jan 26, 2012 20:38 Akorn Inc. (AKRX) Corporate Event Announcement Notice
Jan 25, 2012 20:38 Akorn Inc. (AKRX) Corporate Event Announcement Notice
Jan 25, 2012 09:30 Zacks.com featured expert Kevin Matras highlights: Akorn, Inc., Diana Shipping Inc., Endo Pharmaceuticals Holdings Inc., Southwest Airlines Co. and UnitedHealth Group Inc.
Jan 25, 2012 08:00 Shares of Questcor Pharmaceuticals Rank the Highest in Terms of Relative Performance in the Pharmaceuticals Industry (QCOR, AKRX, RHHBY, VPHM, SLXP)

 
Major Risks
No comments yet. Be the first
make a comment about Major Risks
 


Created by: WikiMigrationBot. Last Modification: Thursday 03 of June, 2010 05:38:52 CDT by WikiMigrationBot.